BIOSTATISTICS/BIOINFORMATICS CORE

生物统计学/生物信息学核心

• 批准号: 8092837
• 负责人: STEPHANIE R LAND
• 金额: $ 8.74万
• 依托单位: UNIVERSITY OF PITTSBURGH AT PITTSBURGH
• 依托单位国家: 美国
• 资助国家: 美国
• 起止时间: 至
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/8092837
• 关键词: Bioinformatics; Biological; Biological Markers; Biometry; Biostatistics Core; Blood Banks; Cancer Biology; Cancer Detection; Cancer Patient; Cells; Clinical; Clinical Sciences; Conduct Clinical Trials; Detection; Development; Diagnosis; Epidermal Growth Factor Receptor; Estrogen Receptors; Goals; Haplotypes; Human; Immunotherapy; Individual; Institution; Intervention; Knowledge; Malignant neoplasm of lung; Nucleotide Excision Repair; Organ; Outcome; Patients; Population; Predisposition; Proteomics; Receptor Signaling; Reproduction spores; Research; Research Personnel; Research Project Grants; Serum; Specialized Program of Research Excellence; Testing; Tissues; Translating; Translational Research; University of Pittsburgh Cancer Institute; Woman; Work; base; cancer risk; career development; cyclin B1; high risk; improved; interdisciplinary approach; meetings; outcome forecast; programs; tool

DESCRIPTION (provided by applicant): The University of Pittsburgh Cancer Institute (UPCI) proposes to continue to conduct a Specialized Program of Research Excellence (SPORE) in Lung Cancer. The overall goals of the UPCI Lung Cancer SPORE are to improve detection and treatment of lung cancer and to understand the mechanisms of lung cancer development in women. The SPORE program will consist of four major translational Research Projects in lung cancer, three Research Cores, an Administrative Core, a Developmental Research Program, and a Career Development Program. The UPCI Lung Cancer SPORE will use an interdisciplinary approach to meet its objectives by carrying out projects with co-investigators in basic, population, and clinical science. It is also organ-specific in its approach and all projects will test hypotheses about lung cancer biology, susceptibility, detection, or treatment. The UPCI SPORE will carry out the directive to translate its findings within five years to human populations by using new knowledge to carry out interventions in humans and to determine the biological basis for observations made in patients with lung cancer or in individuals at high risk for lung cancer. The long-term goal of the UPCI SPORE is to conduct clinical trials based on research results from its translational research projects that will serve as the basis for improving the outcome of patients diagnosed with lung cancer and to define new biological tools that will be useful in identifying asymptomatic lung cancer. The four main Projects are: (1) Intersection of Estrogen Receptor Signaling and Epidermal Growth Factor Receptor Signaling in Lung Cancer; (2) Cyclin B1 in Immunotherapy Diagnosis and Prognosis of Lung Cancer; (3) Serum Proteomic Biomarkers for Lung Cancer Detection and Prognosis; and (4) Nucleotide Excision Repair/Cell Control Haplotypes and Lung Cancer Risk and Prognosis. The three Research Cores will assist the main research Projects, Developmental Research Projects, and Career Development Investigators in carrying out lung cancer translational research. The Research Cores are Clinical Core, Tissue and Blood Bank Core, and Biostatistics/Bioinformatics Core. The Administrative Core will provide scientific and fiscal oversight for the program. UPCI SPORE investigators will work together as a team to meet the goals of the program and will also interact with investigators from Lung Cancer SPOREs at other institutions, the NCI Program Office, and other cooperative groups to improve outcome for lung cancer patients.

描述（由申请人提供）： 匹兹堡大学癌症研究所（UPCI）建议继续开展肺癌卓越研究专业计划（SPORE）。UPCI肺癌SPORE的总体目标是改善肺癌的检测和治疗，并了解女性肺癌发展的机制。SPORE计划将包括四个主要的肺癌转化研究项目，三个研究核心，一个行政核心，一个发展研究计划和一个职业发展计划。UPCI肺癌孢子将采用跨学科的方法，通过与基础，人口和临床科学的合作研究者开展项目来实现其目标。它的方法也是器官特异性的，所有项目都将测试有关肺癌生物学，易感性，检测或治疗的假设。UPCI SPORE将在五年内将其研究结果转化为人类群体，利用新知识对人类进行干预，并确定在肺癌患者或肺癌高危人群中进行观察的生物学基础。UPCI SPORE的长期目标是根据其转化研究项目的研究结果进行临床试验，这些研究结果将作为改善肺癌患者预后的基础，并定义可用于识别无症状肺癌的新生物学工具。四个主要项目是：（1）肺癌中雌激素受体信号传导和表皮生长因子受体信号传导的交叉;（2）肺癌免疫治疗诊断和预后中的细胞周期蛋白B1;（3）肺癌检测和预后的血清蛋白质组生物标志物;（4）核苷酸切除修复/细胞控制单倍型与肺癌风险和预后。这三个研究中心将协助主要研究项目、发展研究项目和职业发展研究人员开展肺癌转化研究。研究核心是临床核心，组织和血库核心，生物统计学/生物信息学核心。行政核心将为该计划提供科学和财政监督。UPCI SPORE研究人员将作为一个团队共同努力，以实现该计划的目标，并将与其他机构，NCI计划办公室和其他合作团体的肺癌SPORE研究人员进行互动，以改善肺癌患者的预后。